Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human adipose-derived mesenchymal stem cell
- Development stage
- Unknown
- Lead developer
- Bopin Good Biotechnology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
BP-001 (human adipose-derived mesenchymal stem cell) is an investigational cell therapy being developed by Bopin Good Biotechnology (Shanghai) Co., Ltd. for the treatment of knee osteoarthritis. These mesenchymal stem cells are isolated from human adipose tissue and expanded ex vivo. Upon intra-articular injection, the cells exert therapeutic effects primarily through paracrine signaling and immunomodulation. They secrete a variety of bioactive molecules, including anti-inflammatory cytokines and growth factors, which help to modulate the joint microenvironment, reduce synovial inflammation, and stimulate endogenous repair mechanisms in the articular cartilage. The therapy aims to provide long-term pain relief and improve joint function by addressing the underlying inflammatory and degenerative processes of osteoarthritis.
- Other names
- human adipose-derived mesenchymal stem cell injectionAD-MSCshAD-MSCs
Beyond the preview
Go deeper on human adipose-derived mesenchymal stem cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human adipose-derived mesenchymal stem cell.